M13 Bacteriophage pVIII Protein: Display Strategies, Chemical Modification, and Antibacterial Activity Investigations

Area of Science:

• Microbiology
• Biotechnology
• Molecular Biology

Background:

• Antibiotic resistance is a growing global health threat, necessitating new therapeutic approaches.
• M13 bacteriophage offers a versatile platform for developing innovative antimicrobial strategies due to its engineering capabilities.

Purpose of the Study:

• To engineer M13 phage major coat protein (pVIII) mutants with specific surface charge properties.
• To evaluate the impact of varying surface charge densities on the bactericidal activity of engineered phages.
• To explore phage-based therapies as an alternative to conventional antibiotics.

Main Methods:

• Genetic engineering and chemical modification of the M13 phage pVIII protein.
• Creation of phage variants with distinct positive and negative surface charge densities.
• Comparative analysis of the antibacterial efficacy of engineered phage variants against bacterial strains.

Main Results:

• Engineered M13 phage variants with tailored surface charges exhibited varying degrees of bactericidal activity.
• Surface charge density was identified as a critical factor influencing the antimicrobial efficacy of the phage variants.
• The study provides a systematic assessment of charge-dependent antibacterial effects.

Conclusions:

• M13 bacteriophage engineering, particularly modification of pVIII surface charge, is a promising avenue for developing novel antimicrobial agents.
• Tailoring phage surface properties can enhance their efficacy against bacterial infections.
• This research contributes to the advancement of phage-based therapies to combat antibiotic resistance.